Discussions on Targeted Systemic Therapies for Refractory Thyroid Cancer

Exploring the challenges of thyroid cancers resistant to radioactive iodine treatment and the emerging targeted systemic therapies like seraphanib and cabazantinib for such cases.

Transcript

Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!

Get the app